APO-PANTOPRAZOLE
APOTEX INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of APO-PANTOPRAZOLE in Canada?
Yes. APO-PANTOPRAZOLE 40MG has an active shortage reported to Health Canada (last updated November 5, 2026).
Why is APO-PANTOPRAZOLE not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will APO-PANTOPRAZOLE be available again?
The manufacturer's estimated resolution date is December 4, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Proton Pump Inhibitor (PPI) Shortage in Canada: Omeprazole, Pantoprazole, Rabeprazole
Why a shortage of one PPI brand rarely means the whole class is unavailable, when a pharmacist can swap manufacturers, and when it needs your prescriber.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
PMS-PANTOPRAZOLE
PHARMASCIENCE INC
PANTOPRAZOLE
SIVEM PHARMACEUTICALS ULC
MINT-PANTOPRAZOLE
MINT PHARMACEUTICALS INC
MAR-PANTOPRAZOLE
MARCAN PHARMACEUTICALS INC
JAMP-PANTOPRAZOLE
JAMP PHARMA CORPORATION
SPC-PANTOPRAZOLE
SUN PHARMA CANADA INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-12-04
~22 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02292920
Strength
40MG
Dosage Form
TABLET (DELAYED-RELEASE)
Route
ORAL
Active Ingredient
PANTOPRAZOLE
Tier
Unrated
Last Updated
2026-11-05
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
APO-PANTOPRAZOLE has 3 shortage/discontinuation reports on file — this is one of them.
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554178
2MG · DIN 02554194